메뉴 건너뛰기
European Urology
Volumn 64, Issue 5, 2013, Pages 857-858
Re: Early detection of prostate cancer: AUA guideline
Author keywords

[No Author keywords available]
Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ERROR; EARLY DIAGNOSIS; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; SYSTEMATIC REVIEW (TOPIC); MALE; MASS SCREENING; NOTE; PROSTATE TUMOR; STANDARD;
EID: 84885407921     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.08.041     Document Type: Editorial
Times cited : (1)
References (8)
  • 1
    • 84856200634 scopus 로고    scopus 로고
    • Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality results after 13 years of follow-up
    • G.L. Andriole, E.D. Crawford, and R.L. Grubb III Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 2012 125 132
    • (2012) J Natl Cancer Inst , vol.104 , pp. 125-132
    • Andriole, G.L.1    Crawford, E.D.2    Grubb III, R.L.3
  • 2
    • 84858212484 scopus 로고    scopus 로고
    • Prostate-cancer mortality at 11 years of follow-up
    • F.H. Schroder, J. Hugosson, and M.J. Roobol Prostate-cancer mortality at 11 years of follow-up N Engl J Med 366 2012 981 990
    • (2012) N Engl J Med , vol.366 , pp. 981-990
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 3
    • 77955279420 scopus 로고    scopus 로고
    • Mortality results from the Goteborg randomised population-based prostate-cancer screening trial
    • J. Hugosson, S. Carlsson, and G. Aus Mortality results from the Goteborg randomised population-based prostate-cancer screening trial Lancet Oncol 11 2011 725 732
    • (2011) Lancet Oncol , vol.11 , pp. 725-732
    • Hugosson, J.1    Carlsson, S.2    Aus, G.3
  • 4
    • 33846959137 scopus 로고    scopus 로고
    • Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years
    • H. Lilja, D. Ulmert, and T. Bjork Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years J Clin Oncol 25 2007 431 436
    • (2007) J Clin Oncol , vol.25 , pp. 431-436
    • Lilja, H.1    Ulmert, D.2    Bjork, T.3
  • 5
    • 77956811462 scopus 로고    scopus 로고
    • Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
    • A.J. Vickers, A.M. Cronin, and T. Bjork Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study BMJ 341 2010 c4521
    • (2010) BMJ , vol.341 , pp. 4521
    • Vickers, A.J.1    Cronin, A.M.2    Bjork, T.3
  • 6
    • 79955705831 scopus 로고    scopus 로고
    • Radical prostatectomy versus watchful waiting in early prostate cancer
    • A. Bill-Axelson, L. Holmberg, and M. Ruutu Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 364 2011 1708 1717
    • (2011) N Engl J Med , vol.364 , pp. 1708-1717
    • Bill-Axelson, A.1    Holmberg, L.2    Ruutu, M.3
  • 7
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • T.J. Wilt, M.K. Brawer, and K.M. Jones Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
    • (2012) N Engl J Med , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 8
    • 84865029404 scopus 로고    scopus 로고
    • Quality-of-life effects of prostate-specific antigen screening
    • E.A. Heijnsdijk, E.M. Wever, and A. Auvinen Quality-of-life effects of prostate-specific antigen screening N Engl J Med 367 2012 595 605
    • (2012) N Engl J Med , vol.367 , pp. 595-605
    • Heijnsdijk, E.A.1    Wever, E.M.2    Auvinen, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.